vs
Side-by-side financial comparison of CRYO CELL INTERNATIONAL INC (CCEL) and CSP INC (CSPI). Click either name above to swap in a different company.
CSP INC is the larger business by last-quarter revenue ($12.0M vs $7.8M, roughly 1.5× CRYO CELL INTERNATIONAL INC). CSP INC runs the higher net margin — 0.8% vs -48.7%, a 49.4% gap on every dollar of revenue. On growth, CRYO CELL INTERNATIONAL INC posted the faster year-over-year revenue change (-2.3% vs -23.2%). CRYO CELL INTERNATIONAL INC produced more free cash flow last quarter ($1.2M vs $-3.0M). Over the past eight quarters, CRYO CELL INTERNATIONAL INC's revenue compounded faster (-0.1% CAGR vs -6.3%).
Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.
CSP Inc. is a U.S.-based technology firm offering cybersecurity solutions, managed IT services, high-performance computing systems, and IT consulting support. It serves enterprises across healthcare, finance, manufacturing, and public sectors in North America and select global markets.
CCEL vs CSPI — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $7.8M | $12.0M |
| Net Profit | $-3.8M | $91.0K |
| Gross Margin | 77.9% | 39.3% |
| Operating Margin | -50.6% | -0.9% |
| Net Margin | -48.7% | 0.8% |
| Revenue YoY | -2.3% | -23.2% |
| Net Profit YoY | -105.1% | -80.7% |
| EPS (diluted) | $-0.46 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $7.8M | $12.0M | ||
| Q3 25 | $7.8M | $14.5M | ||
| Q2 25 | $7.9M | $15.4M | ||
| Q1 25 | $8.0M | $13.1M | ||
| Q4 24 | $8.0M | $15.7M | ||
| Q3 24 | $8.1M | $13.0M | ||
| Q2 24 | $8.0M | $13.1M | ||
| Q1 24 | $7.9M | $13.7M |
| Q4 25 | $-3.8M | $91.0K | ||
| Q3 25 | $749.4K | $-191.0K | ||
| Q2 25 | $355.8K | $-264.0K | ||
| Q1 25 | $282.9K | $-108.0K | ||
| Q4 24 | $-1.9M | $472.0K | ||
| Q3 24 | $1.1M | $-1.7M | ||
| Q2 24 | $655.8K | $-185.0K | ||
| Q1 24 | $556.2K | $1.6M |
| Q4 25 | 77.9% | 39.3% | ||
| Q3 25 | 77.0% | 36.6% | ||
| Q2 25 | 76.6% | 28.8% | ||
| Q1 25 | 75.1% | 32.0% | ||
| Q4 24 | 78.4% | 29.1% | ||
| Q3 24 | 73.6% | 28.4% | ||
| Q2 24 | 74.8% | 35.0% | ||
| Q1 24 | 73.7% | 47.3% |
| Q4 25 | -50.6% | -0.9% | ||
| Q3 25 | 24.3% | -3.7% | ||
| Q2 25 | 18.8% | -7.9% | ||
| Q1 25 | 13.3% | -7.6% | ||
| Q4 24 | -1.5% | -2.3% | ||
| Q3 24 | 17.2% | -15.7% | ||
| Q2 24 | 17.3% | -5.5% | ||
| Q1 24 | 10.5% | 9.0% |
| Q4 25 | -48.7% | 0.8% | ||
| Q3 25 | 9.6% | -1.3% | ||
| Q2 25 | 4.5% | -1.7% | ||
| Q1 25 | 3.5% | -0.8% | ||
| Q4 24 | -23.2% | 3.0% | ||
| Q3 24 | 13.0% | -12.7% | ||
| Q2 24 | 8.2% | -1.4% | ||
| Q1 24 | 7.1% | 11.6% |
| Q4 25 | $-0.46 | $0.01 | ||
| Q3 25 | $0.09 | $-0.02 | ||
| Q2 25 | $0.04 | $-0.03 | ||
| Q1 25 | $0.03 | $-0.01 | ||
| Q4 24 | $-0.23 | $0.05 | ||
| Q3 24 | $0.13 | $-0.17 | ||
| Q2 24 | $0.08 | $-0.02 | ||
| Q1 24 | $0.07 | $0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.3M | $24.9M |
| Total DebtLower is stronger | $8.4M | — |
| Stockholders' EquityBook value | $-18.6M | $44.8M |
| Total Assets | $61.7M | $69.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.3M | $24.9M | ||
| Q3 25 | $3.2M | $27.4M | ||
| Q2 25 | $4.4M | $26.3M | ||
| Q1 25 | $3.5M | $29.5M | ||
| Q4 24 | $3.5M | $30.7M | ||
| Q3 24 | $2.1M | $30.6M | ||
| Q2 24 | $1.5M | $28.9M | ||
| Q1 24 | $979.6K | $27.1M |
| Q4 25 | $8.4M | — | ||
| Q3 25 | $8.4M | — | ||
| Q2 25 | $8.4M | — | ||
| Q1 25 | $8.5M | — | ||
| Q4 24 | $8.5M | — | ||
| Q3 24 | $8.5M | — | ||
| Q2 24 | $8.5M | — | ||
| Q1 24 | $8.6M | — |
| Q4 25 | $-18.6M | $44.8M | ||
| Q3 25 | $-14.8M | $44.6M | ||
| Q2 25 | $-15.6M | $47.5M | ||
| Q1 25 | $-14.7M | $47.5M | ||
| Q4 24 | $-13.2M | $47.5M | ||
| Q3 24 | $-9.6M | $47.3M | ||
| Q2 24 | $-10.7M | $48.1M | ||
| Q1 24 | $-10.3M | $48.2M |
| Q4 25 | $61.7M | $69.2M | ||
| Q3 25 | $63.2M | $71.2M | ||
| Q2 25 | $64.4M | $66.8M | ||
| Q1 25 | $64.4M | $67.1M | ||
| Q4 24 | $64.7M | $67.5M | ||
| Q3 24 | $62.9M | $69.4M | ||
| Q2 24 | $62.6M | $66.8M | ||
| Q1 24 | $61.7M | $64.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.3M | $-2.9M |
| Free Cash FlowOCF − Capex | $1.2M | $-3.0M |
| FCF MarginFCF / Revenue | 15.5% | -25.1% |
| Capex IntensityCapex / Revenue | 0.9% | 0.9% |
| Cash ConversionOCF / Net Profit | — | -32.04× |
| TTM Free Cash FlowTrailing 4 quarters | $5.2M | $-2.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.3M | $-2.9M | ||
| Q3 25 | $2.5M | $1.9M | ||
| Q2 25 | $707.0K | $-3.3M | ||
| Q1 25 | $954.1K | $1.9M | ||
| Q4 24 | $2.2M | $1.7M | ||
| Q3 24 | $2.4M | $-1.5M | ||
| Q2 24 | $1.8M | $2.4M | ||
| Q1 24 | $-356.9K | $1.7M |
| Q4 25 | $1.2M | $-3.0M | ||
| Q3 25 | $2.5M | $1.7M | ||
| Q2 25 | $644.6K | $-3.3M | ||
| Q1 25 | $892.0K | $1.9M | ||
| Q4 24 | $2.1M | $1.7M | ||
| Q3 24 | $2.3M | $-1.5M | ||
| Q2 24 | $21.5K | $2.4M | ||
| Q1 24 | $-814.6K | $1.6M |
| Q4 25 | 15.5% | -25.1% | ||
| Q3 25 | 31.9% | 11.5% | ||
| Q2 25 | 8.1% | -21.7% | ||
| Q1 25 | 11.2% | 14.5% | ||
| Q4 24 | 26.8% | 10.8% | ||
| Q3 24 | 27.9% | -11.7% | ||
| Q2 24 | 0.3% | 17.9% | ||
| Q1 24 | -10.4% | 11.9% |
| Q4 25 | 0.9% | 0.9% | ||
| Q3 25 | 0.5% | 1.6% | ||
| Q2 25 | 0.8% | 0.4% | ||
| Q1 25 | 0.8% | 0.1% | ||
| Q4 24 | 0.1% | 0.3% | ||
| Q3 24 | 2.3% | 0.1% | ||
| Q2 24 | 21.8% | 0.3% | ||
| Q1 24 | 5.8% | 0.1% |
| Q4 25 | — | -32.04× | ||
| Q3 25 | 3.38× | — | ||
| Q2 25 | 1.99× | — | ||
| Q1 25 | 3.37× | — | ||
| Q4 24 | — | 3.69× | ||
| Q3 24 | 2.32× | — | ||
| Q2 24 | 2.70× | — | ||
| Q1 24 | -0.64× | 1.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCEL
Segment breakdown not available.
CSPI
| Products | $6.7M | 56% |
| Services | $5.3M | 44% |
